1) Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS:Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS 25:691-700, 2011
2) Flinn IW, Ambinder RF:AIDS primary central nervous system lymphoma. Curr Opin Oncol 8:373-376, 1996
3) Gildenberg PL, Gathe JC Jr, Kim JH:Stereotactic biopsy of cerebral lesions in AIDS. Clin Infect Dis 30:491-499, 2000
4) Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ:Spectrum of AIDS-associated malignant disorders. Lancet 351(9119):1833-1839, 1998
5) Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL:Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol 19:99-108, 2017
6) Hishima T, Oyaizu N, Fujii T, Tachikawa N, Ajisawa A, Negishi M, Nakamura T, Iwamoto A, Hayashi Y, Matsubara D, Sasao Y, Kimura S, Kikuchi Y, Teruya K, Yasuoka A, Oka S, Saito K, Mori S, Funata N, Sata T, Katano H:Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy. Microbes Infect 8:1301-1307, 2006
7) 神野定男,松永直久:HIV感染者に関する医療機器の滅菌・消毒法と針刺し・切創・血液曝露後の対応.治療93:2285-2289, 2011
8) Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL;US Public Health Service Working Group:Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 34:875-892, 2013
9) 森 茂郎:AIDSリンパ腫.医学のあゆみ162:118-121, 1992
10) 中村哲也:AIDS関連悪性リンパ腫.日本臨牀58:669-672, 2000
11) 岡田誠治:AlDS関連悪性リンパ腫—その現状と治療戦略.医学のあゆみ235:431-437, 2010
Tl single-photon emission computed tomography. AJR Am J Roentgenol 163:417-421, 1994
13) 矢崎博久:HIV/AIDS.臨床と微生物41:79-83, 2014